September 16, 2024

SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade | Cell Death & Disease – Nature.com

September 16, 2024

Immunotherapy after surgery helps people with high-risk bladder cancer live cancer-free longer – National Institutes of Health

September 16, 2024

Neoadjuvant TAR-200/Cetrelimab Combo Shows Activity in Muscle-Invasive Bladder Cancer – OncLive

September 15, 2024

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer – nejm.org

September 15, 2024

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

New England Journal of Medicine, Ahead of Print.